Rinaldi Valerio, Illuminati Giulio, Caronna Roberto, Prezioso Giampaolo, Palumbo Piergaspare, Saullo Paolina, D'Andrea Vito, Nardi Priscilla
Department of Surgery, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
J Clin Med. 2024 Sep 28;13(19):5793. doi: 10.3390/jcm13195793.
: Giant splenic artery aneurysms (SAAs) and pseudoaneurysms (SAPs) represent rare conditions, characterized by a diameter greater than or equal to 5 cm. The risk of rupture is increased compared to common SAAs and SAPs, necessitating urgent treatments to prevent it. : This systematic review was conducted through a comprehensive search involving the PubMed, Google Scholar, and Scopus databases. A total of 82 patients and 65 articles were included in the analysis. For each patient, we investigated age, sex, symptoms, comorbidities, the presence of a true or a false aneurysm, the dimensional criteria used to define dilations as giant aneurysms or pseudoaneurysms, the dimension of the two greatest diameters, imaging studies, surgical treatment, post-operative length of stay (LOS), and post-operative follow-up. : The results revealed a similar incidence in both genders (43 males vs. 39 females) with a median age of 55.79 years. The most frequently described symptom was pain (59.76%). Thirteen cases were false aneurysms and 69 were true aneurysms. The mean greatest diameter was 9.90 cm. The CT scan was the most utilized imaging study (80.49%). Open, endovascular, and hybrid surgery were performed in 47, 26, and 9 patients, respectively, with complication rates of 14.89%, 23.08%, and 22.22% occurring for each treatment. The post-operative LOS was 12.29 days, 2.36 days, and 5 days, respectively. The median follow-up was 17.28 months overall. No recanalization was observed after endovascular procedures during the follow-up period. : The dimensional criterion to define SAAs and SAPs as giant was most frequently that at least one diameter was ≥ 5 cm. The CT scan was the most frequently utilized radiological study to diagnose giant SAAs and SAPs. Finally, endovascular procedures, open surgeries, and hybrid treatments presented similar post-operative complication rates. The post-operative LOS was lower for the endovascular group, and the follow-up period did not show aneurysm recanalization in any patients.
巨大脾动脉瘤(SAAs)和假性动脉瘤(SAPs)是罕见病症,其特征为直径大于或等于5厘米。与普通的SAAs和SAPs相比,破裂风险增加,因此需要紧急治疗以预防破裂。
本系统评价通过全面检索PubMed、谷歌学术和Scopus数据库进行。分析共纳入82例患者和65篇文章。对于每位患者,我们调查了年龄、性别、症状、合并症、真性或假性动脉瘤的存在情况、用于将扩张定义为巨大动脉瘤或假性动脉瘤的尺寸标准、两个最大直径的尺寸、影像学检查、手术治疗、术后住院时间(LOS)以及术后随访情况。
结果显示,两性发病率相似(43例男性对39例女性),中位年龄为55.79岁。最常描述的症状是疼痛(59.76%)。13例为假性动脉瘤,69例为真性动脉瘤。平均最大直径为9.90厘米。CT扫描是最常用的影像学检查(80.49%)。分别有47例、26例和9例患者接受了开放手术、血管内手术和杂交手术,每种治疗的并发症发生率分别为14.89%、23.08%和22.22%。术后住院时间分别为12.29天、2.36天和5天。总体中位随访时间为17.28个月。随访期间血管内手术后未观察到再通情况。
将SAAs和SAPs定义为巨大的尺寸标准最常见的是至少一个直径≥5厘米。CT扫描是诊断巨大SAAs和SAPs最常用的放射学检查。最后,血管内手术、开放手术和杂交治疗的术后并发症发生率相似。血管内手术组的术后住院时间较短,随访期间未发现任何患者的动脉瘤再通情况。